These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8265258)

  • 21. The presence of IgM antiphospholipid antibodies in patients with Henoch-Schonlein purpura and recurrent palpable purpura.
    Kawakami T; Takeuchi S; Soma Y
    Arch Dermatol; 2011 Aug; 147(8):986-8. PubMed ID: 21844466
    [No Abstract]   [Full Text] [Related]  

  • 22. Henoch-Schönlein purpura associated with anti-Ro (SSA) and antiphospholipid antibody syndrome.
    Garber ME; Mohr BW; Calabrese LH
    J Rheumatol; 1993 Nov; 20(11):1964-6. PubMed ID: 8308787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophil cationic protein in Henoch-Schönlein purpura.
    Luca CM; Laicini EA; Fossali EF
    World J Pediatr; 2014 Feb; 10(1):90-1. PubMed ID: 24464674
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiphospholipid antibodies in children with Henoch-Schonlein purpura: a prospective study from North India.
    Salhan M; Ahluwalia J; Singh S; Minz RW
    Scand J Rheumatol; 2007; 36(6):482-4. PubMed ID: 18092274
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoglobulin A multiple myeloma presenting with Henoch-Schönlein purpura associated with reduced sialylation of IgA1.
    Van Der Helm-Van Mil AH; Smith AC; Pouria S; Tarelli E; Brunskill NJ; Eikenboom HC
    Br J Haematol; 2003 Sep; 122(6):915-7. PubMed ID: 12956761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Henoch-Schönlein purpura and stroke: antiphosphatidylethanolamine antibody in CSF and serum.
    Sokol DK; McIntyre JA; Short RA; Gutt J; Wagenknecht DR; Biller J; Garg B
    Neurology; 2000 Nov; 55(9):1379-81. PubMed ID: 11087785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Children with Henoch-Schönlein purpura with low complement levels: follow-up for >6 years.
    Lin Q; Li X
    Pediatr Nephrol; 2017 Jul; 32(7):1279. PubMed ID: 28353010
    [No Abstract]   [Full Text] [Related]  

  • 28. No pathogenic role of enhanced plasma IgA binding capacity to fibronectin and IgA-fibronectin aggregates in Henoch-Schönlein purpura.
    Davin JC; Li Vecchi M; Mahieu P
    Nephron; 1996; 74(2):435-6. PubMed ID: 8893175
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
    Ru L; Abudouhaer A; Guo YF
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes of peripheral blood dendritic cell functions in children with Henoch-Schonlein purpura and in vitro effect of Astragalus membranaceus].
    Chen YX; Zhang QY; Wang J
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):708-9. PubMed ID: 19099866
    [No Abstract]   [Full Text] [Related]  

  • 31. Henoch-Schönlein purpura with posterior reversible encephalopathy syndrome.
    Dasarathi M; Birchall D; De San Lazaro C; Fawcett LK; Eyre JA
    Pediatr Neurol; 2012 Jan; 46(1):42-3. PubMed ID: 22196491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of factors VIII and IX in a child with Henoch-Schönlein syndrome.
    Gouyon JB; Seiller F; Deries X; Alison M; Lorenzini JL; Devilliers E
    Am J Pediatr Hematol Oncol; 1985; 7(4):376-7. PubMed ID: 3936372
    [No Abstract]   [Full Text] [Related]  

  • 33. Pediatric acute lymphoblastic leukemia mimicking Henoch-Schönlein purpura.
    Funato M; Kaneko H; Kubota K; Ozeki M; Kanda K; Orii K; Kato Z; Fukao T; Kondo N
    Pediatr Int; 2011 Oct; 53(5):766-768. PubMed ID: 21955011
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
    Li MM; Liu N; Zhagn M; Xue HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):181-185. PubMed ID: 28245398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cut-off values for serum matrix metalloproteinase-9: is there a threshold to predict renal involvement for Henoch-Schonlein purpura in children?
    Qin YH; Zhou TB; Lei FY; Huang WF; Zhao YJ; Lin FQ; Su LN
    Nephrology (Carlton); 2011 Jan; 16(1):93-9. PubMed ID: 21175984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is low serum complement 3 in Henoch Schönlein purpura unusual and of prognostic value?
    Islek I; Muslu A; Dagdemir A; Dilber C
    Eur J Pediatr; 2001 Jun; 160(6):397-8. PubMed ID: 11421425
    [No Abstract]   [Full Text] [Related]  

  • 37. Goodpasture syndrome during the course of a Schönlein-Henoch purpura.
    Carreras L; Poveda R; Bas J; Mestre M; Rama I; Carrera M
    Am J Kidney Dis; 2002 May; 39(5):E21. PubMed ID: 11979333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryoglobulinaemia in Henoch-Schönlein purpura.
    Garcia-Fuentes M; Chantler C; Williams DG
    Br Med J; 1977 Jul; 2(6080):163-5. PubMed ID: 871825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Platelet aggregation and Schoenlein-Henoch syndrome].
    Sardella M; Arturi L; Caroni G; Maiullari E; Lange MM; Corsi CM
    Minerva Pediatr; 1983 Nov; 35(22):1085-96. PubMed ID: 6672596
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic value of plasma factor XIII in Henoch-Schönlein purpura.
    Kaneko K; Fujii S; Shono T; Matsumoto Y; Arii N; Kaneko K
    Pediatr Nephrol; 2004 Jun; 19(6):702-3. PubMed ID: 15054647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.